Skip to main content

Advertisement

Table 1 Clinical and demographical characteristics of the patients or ulcers

From: Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers

Characteristics Results (N = 1788 patients)
Age (years): median ± QR (minimum; maximum) 65.0 ± 14.0 (19; 98)
Gender: masculine/feminine (% feminine) 825/963 (53.9%)
Ethnic groups (24 missing) White 1132 (63.3%)
Black 289 (16.2%)
Mixed 333 (18.6%)
  Chinese 10 (0.6%)
Diabetes mellitus: type 1/type 2 (% type 2) (47 missing) 379/1362 (76.2%)
Smokers (6 missing) 368 (20.6%)
Arterial hypertension (4 missing) 1085 (60.7%)
Ischemic cardiopathy (9 missing) 411 (23.0%)
Antecedents of foot ulcers 662 (37.0%)
Antecedents of amputations 420 (23.5%)
  N = 1835 ulcers
Etiology of the ulcer (1 missing) Ischemic 790 (43.1%)
Non ischemic 1044 (56.9%)
Location-extension of the lesion (118 missing) Simple 1140 (62.1%)
Complex 354 (19.3%)
  Calcaneal 223 (12.2%)
Wagner’s classification (83 missing)   
Grade 1 26 (1.4%)
Grade 2 228 (12.4%)
Grade 3 981 (53.5%)
Grade 4 504 (27.5%)
  Grade 5 13 (0.7%)